DNPUF
Price:
$4.13
Market Cap:
$222.48B
Sumitomo Pharma Co., Ltd. engages in the manufacture and sale of pharmaceuticals, food ingredients and additives, veterinary medicines, and others in Japan, North America, China, and internationally. The company offers pharmaceutical products, such as therapeutic agents for Parkinson's disease, uterine fibroids, depression, type 2 diabetes, systemic fungal infection, hypertension, pruritus, advanced prostate cancer, overactive bladder, chronic obstructive pulmonary disease, angina pectoris, and arrhythmia. It also provides products for atypical antipsychotic, cultured thymus tissue for pediatric congenital athymia, antiepileptic, and carbapenem antibiotic; and Fabry disease drugs. In additio...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2012-01-17
Stock Exchange
PNK
Ticker
DNPUF
According to Sumitomo Pharma Co., Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 512.78B. This represents a change of -2.58% compared to the average of 526.34B of the last 4 quarters.
The mean historical Enterprise Value of Sumitomo Pharma Co., Ltd. over the last ten years is 666.37B. The current 512.78B Enterprise Value has changed 7.60% with respect to the historical average. Over the past ten years (40 quarters), DNPUF's Enterprise Value was at its highest in in the December 2018 quarter at 1.28T. The Enterprise Value was at its lowest in in the December 2022 quarter at 380.84B.
Average
666.37B
Median
615.47B
Minimum
510.99B
Maximum
985.42B
Discovering the peaks and valleys of Sumitomo Pharma Co., Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 61.76%
Maximum Annual Enterprise Value = 985.42B
Minimum Annual Increase = -35.44%
Minimum Annual Enterprise Value = 510.99B
Year | Enterprise Value | Change |
---|---|---|
2024 | 551.14B | 7.42% |
2023 | 513.04B | -6.03% |
2022 | 545.99B | -35.44% |
2021 | 845.71B | 12.21% |
2020 | 753.68B | -23.52% |
2019 | 985.42B | 61.76% |
2018 | 609.20B | -16.18% |
2017 | 726.83B | 42.24% |
2016 | 510.99B | -17.81% |
2015 | 621.73B | -14.11% |
The current Enterprise Value of Sumitomo Pharma Co., Ltd. (DNPUF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
536.73B
5-year avg
641.91B
10-year avg
666.37B
Sumitomo Pharma Co., Ltd.’s Enterprise Value is greater than Hypera S.A. (19.33B), greater than Indivior PLC (1.50B), greater than YourWay Cannabis Brands Inc. (17.82M), greater than Cumberland Pharmaceuticals Inc. (39.26M), greater than RAMM Pharma Corp. (529.77K), greater than Genomma Lab Internacional, S.A.B. de C.V. (27.58B), greater than Speakeasy Cannabis Club Ltd. (2.88M), greater than City View Green Holdings Inc. (2.86M), greater than Craftport Cannabis Corp. (9.02B), greater than Orexo AB (publ) (1.08B), greater than Indivior PLC (1.50B), greater than C21 Investments Inc. (34.00M), greater than RavenQuest BioMed Inc. (13.59M), greater than Bhang Inc. (-323622.00), greater than Willow Biosciences Inc. (9.55M), greater than Alpha Teknova, Inc. (482.89M), greater than Guardion Health Sciences, Inc. (-10475955.00), greater than Lifecore Biomedical, Inc. (411.23M), greater than Organogenesis Holdings Inc. (413.14M), greater than Petros Pharmaceuticals, Inc. (6.24M),
Company | Enterprise Value | Market cap |
---|---|---|
19.33B | $1.85B | |
1.50B | $2.89B | |
17.82M | $17.82M | |
39.26M | $35.25M | |
529.77K | $15.16M | |
27.58B | $1.27B | |
2.88M | $1.31K | |
2.86M | $730.24K | |
9.02B | $6.28B | |
1.08B | $38.58M | |
1.50B | $3.01B | |
34.00M | $21.37M | |
13.59M | $482.11K | |
-323622.00 | $23.48K | |
9.55M | $6.06M | |
482.89M | $458.45M | |
-10475955.00 | $4.35M | |
411.23M | $279.89M | |
413.14M | $399.81M | |
6.24M | $2.89M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sumitomo Pharma Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Sumitomo Pharma Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Sumitomo Pharma Co., Ltd.'s Enterprise Value?
What is the highest Enterprise Value for Sumitomo Pharma Co., Ltd. (DNPUF)?
What is the 3-year average Enterprise Value for Sumitomo Pharma Co., Ltd. (DNPUF)?
What is the 5-year average Enterprise Value for Sumitomo Pharma Co., Ltd. (DNPUF)?
How does the current Enterprise Value for Sumitomo Pharma Co., Ltd. (DNPUF) compare to its historical average?